Rachael Ferrari, MD, addresses the mental health challenges patients face with intellectual and developmental disabilities (IDDs) and shares tools for how to better serve and support these individuals.

Thomas Mroz, MD, explains the surgical landscape of cervical spondylotic myelopathy treatment and discusses advancements in the field, along with promising research developments.

Stephen Ferber, MD, discusses the selection, administration and effectiveness of interventions for treatment-resistant psychiatric disorders.

Dylan Wint, MD, details the neuropsychiatric symptoms of dementia and their management.

Rebecca Kuenzler, MD, provides the latest insights on the diagnosis and treatment of amyotrophic lateral sclerosis.

Edward Kilbane, MD, addresses diagnosis of bipolar disorders and details the current treatment landscape.

Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.

Demitre Serletis, MD, PhD, details the current and future use of SEEG in the localization of seizure foci and surgical planning as part of a team that has completed more than 1,000 SEEG cases.

The incidence of behavioral health conditions in individuals with multiple sclerosis is four times higher than those with other neurological conditions. In this episode, Grace Tworek, PsyD, discusses the management of behavioral health conditions in MS.

Bill Clifton, MD, discusses the considerations and value of early intervention in adult idiopathic scoliosis.